| Popis: |
Objectives To provide basis for the safe use of indigenous dexmedetomidine hydrochloride by observing its sedative effect and safety when it was given to mechanically ventilated patients of different ages. Methods Three hundred and fourteen mechanically ventilated patients were admitted to our ICU. According to the age, patients were divided into two subgroups: group A (25-50 years old) and group B (51-80 years old), with 157 patients in each group. Dexmedetomidine was given to achieve the target sedation level (Ramsay score 3). The changes in noninvasive blood pressure (SBP, DBP, MAP), heart rate, SpO2, respiratory rate and FiO2 were continuously monitored and recorded before treatment (T1), and 10min (T2), 30min (T3) and 120min (T4) after drug administration, on the instant moment of extubation (T5), and 30min after extubation (T6). The adverse reactions such as hypertension, hypotension, bradycardia, tachycardia, delirium were also observed and recorded after treatment. Results Patients of both A and B groups showed a lowering of SBP, DBP, MAP and HR after treatment with dexmedetomidine, especially in group B(P80mmHg, HR>60 times/min). Respiratory rate was reduced (P0.05). SpO2 was not reduced, and it even rose 30min after administration of dexmedetomidine (P0.05), and the heart rate was slightly slower in group B (P |
